Zydus Lifesciences informs about press release

22 Jul 2024 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated July 22, 2024 titled ‘Zydus receives approval from COFEPRIS of Mexico to market Bhava™ (Bevacizumab biosimilar) to treat various cancers’.

The above information is a part of company’s filings submitted to BSE.


Zydus Lifesciences Share Price

915.50 14.20 (1.58%)
31-Dec-2025 15:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.85
Dr. Reddys Lab 1270.80
Cipla 1510.15
Zydus Lifesciences 915.50
Lupin 2107.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×